Tag: reversible thrombolytic
Reversible thrombolytic drug restores blood flow in microfluidic model of acute...
Basking Biosciences has announced the publication of preclinical research in Communications Biology—a Nature Portfolio journal—showing that its lead candidate, BB-031, restored blood flow in...
Basking doses first patients in phase-one study of stroke drug reversal...
Basking Biosciences has announced that the first participants have been dosed in a phase-one clinical study of BB-025—a rapid-acting reversal agent designed to specifically...
Reversible thrombolytic could alleviate US “tribalism” around tPA and help redefine...
Following Basking Biosciences’ recent announcement that the first acute ischaemic stroke patients have received its novel thrombolytic therapy as part of the Phase 2...
